FFVM
ROIV icon

Founders Fund VI Management’s Roivant Sciences ROIV Stock Holding History

Founders Fund VI Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,119,489
Closed -$12.6M – 4
2023
Q4 		$12.6M Hold
1,119,489
– – 98.63% 1
2023
Q3 		$13.1M Hold
1,119,489
– – 99.02% 1
2023
Q2 		$11.3M Hold
1,119,489
– – 97.24% 1
2023
Q1 		$8.26M Hold
1,119,489
– – 96.9% 1
2022
Q4 		$8.94M Hold
1,119,489
– – 96.26% 1
2022
Q3 		$3.6M Hold
1,119,489
– – 81.82% 1
2022
Q2 		$4.56M Hold
1,119,489
– – 64.36% 1
2022
Q1 		$5.53M Hold
1,119,489
– – 9.33% 3
2021
Q4 		$9.1M Buy
+1,119,489
New +$9.31M 14.2% 3

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Founders Fund VI Management's ROIV Position: Q1 2024 in Review

Founders Fund VI Management sold out of Roivant Sciences (ROIV) in Q1 2024, closing a stake of 1,119,489 shares — an estimated $12.6M sold.

Founders Fund VI Management first reported a position in ROIV in Q4 2021 and held it in 9 quarters. The position peaked at $13.1M in Q3 2023. 259 funds tracked by Wall St. Rank hold ROIV as of Q1 2024.

  • Founders Fund VI Management reported no remaining Roivant Sciences position as of Q1 2024 after selling out during the quarter.
  • Founders Fund VI Management sold 1,119,489 Roivant Sciences shares in Q1 2024, an estimated $12.6M.
  • Founders Fund VI Management first reported a position in Roivant Sciences in Q4 2021 and held it in 9 quarters.
  • Founders Fund VI Management's Roivant Sciences position peaked at $13.1M in Q3 2023.
  • 259 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2024.

Based on Founders Fund VI Management's 13F filing for Q1 2024, filed 15 May 2024.